# Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients

> **NCT02181946** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT02181946
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2001-07
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181946, "Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02181946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*